SMFG $8.38 -0.3567%
EVRI $14.43 -1.1309%
BA $199.31 -1.2526%
EMFQ $21.58 0%
INCH.L $775.00 0.8458%
AGOV $77.40 0%
ODPV3.SA $11.11 0.3613%
ACS.MC $31.23 -1.4205%
0QZM.L $119.37 0%
NWBI $10.40 0.7752%
1398.HK $4.33 -2.0362%
NHF $14.66 0%
NN $2.87 0.7018%
ICFI $114.38 -0.4959%
DUNEU $9.95 0%
ITRI $65.96 -0.8269%
GDSTU $10.50 0%
PRLHW $0.11 -11.1198%
0DXG.L $10.30 0.0253%
FOX.L $1.09 0%
EUO $29.18 1.214%
ENO $24.12 0.4581%
HLAHU $10.06 0%
1317.HK $0.36 0%
PHYL $33.96 -0.1764%
1827.HK $1.42 2.1583%
AEL-PA $21.47 1.3782%
IRR.L $23.50 0%
EFL $8.63 0%
LITM $2.68 1.9011%
XFAB.PA $8.25 1.1029%
ILCG $55.87 -0.7551%
CRON $1.71 -2.8409%
CRBP $9.75 4.2781%
TBLD $15.07 -0.0663%
0J5Z.L $40.23 0.1319%
1611.HK $2.52 0%
CIE.MC $27.90 -0.2859%
0ISM.L $0.78 -2.5031%
AVNW $29.46 -0.408%
ALPLA.PA $0.27 2.6316%
HCTI $0.29 -14.4118%
PCT $7.10 -7.5169%
CANO $1.20 -6.25%
GLEN.L $432.30 1.0992%
ASCA $10.50 0.9615%
VBND $43.59 -0.2743%
VDTS.L $22.32 0.47276%
LCTU $45.03 -0.7341%
AUE.SI $0.96 -0.5208%
SMH.L $23.30 0%
ANDAU $11.10 0%
BWC $9.92 0%
ABF.L $1 915.50 0.3931%
PUAL.L $122.50 0%
AMRN $1.22 3.3898%
SEER3.SA $3.61 -0.8242%
VIACP $52.36 0%
MRL.L $514.00 0.7843%
6996.HK $2.46 -6.1069%
PCB $13.20 -1.4925%
CAMB.L $82.50 0%
USRI.L $7 494.75 0.3011%
0430.HK $0.38 1.3333%
FINM $10.14 0%
REI $1.73 3.5928%
GDO $12.54 -0.0797%
1718.HK $0.18 0.5714%
NETC $10.58 -0.0009%
JRI $11.32 -0.0265%
PFFL $9.34 -0.1657%
0011.HK $113.40 -0.439%
0R08.L $167.99 -1.0864%
UVV $52.09 -0.7621%
DIVI $29.32 -0.2218%
P8ET.IR $0.01 0%
RMCF $5.47 2.8195%
GAQ-UN $10.45 0%
2722.HK $0.66 -2.9412%
SPUU $79.60 -1.0124%
DSWL $2.78 0.7246%
PCT.L $2 005.00 -0.4963%
TC $0.53 -4.3668%
HFD.L $198.60 -0.0503%
EOLS $10.26 -0.3883%
OFG $23.17 -1.5325%
SHIPZ $0.01 0%
IONS $35.53 -0.1686%
NUWE $2.89 -7.0739%
SHACU $10.05 0%
GAMR $59.76 -1.2723%
IEAH.L $4.72 -0.1798%
WRE $17.57 0%
DOM.MC $3.67 -0.4071%
EDOC.L $9.17 0.7307%
AOR $49.91 -0.4488%
EVV $9.05 -1.6304%
0LCX.L $125.50 -0.2061%
PRPL $3.02 1.1745%
Eng
Логотип
Eng
Лого

OKYO Pharma Limited OKYO.L

$2.05

На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    33960960.00000000

  • week52high

    8.50

  • week52low

    1.35

  • Revenue

    0

  • P/E TTM

    -598

  • Beta

    -0.02480900

  • EPS

    -0.01000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    30 дек 2022 г. в 07:00

Описание компании

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек